Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu

被引:88
作者
Zhang, Jinli [1 ]
Zhang, Qianqian [2 ]
Liu, Guang [1 ]
Zhang, Ning [1 ]
机构
[1] Hebei Med Univ, Dept Cardiol, Affiliated Hosp 4, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Basic Med, 361 Zhongshan East Rd, Shijiazhuang 050017, Hebei, Peoples R China
关键词
Dashensu; Chinese traditional medicine; Cardiovascular disease; Anti-oxidiation; Anti-apoptosis; ISCHEMIA-REPERFUSION INJURY; SALVIA-MILTIORRHIZA; BIOLOGICAL EVALUATION; AQUEOUS EXTRACT; ISCHEMIA/REPERFUSION INJURY; CARDIAC-HYPERTROPHY; SODIUM DANSHENSU; DOWN-REGULATION; P-GLYCOPROTEIN; GLOBAL BURDEN;
D O I
10.1016/j.ejphar.2019.172710
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Danshensu is a pure molecule derived from Danshen, which is the root of the herb Salvia miltiorrhiza. It has a clearly defined chemical structure and demonstrates therapeutic effects in cardiovascular diseases (e.g., myocardial ischemia and reperfusion, atherosclerosis, hypertension), cerebral lesions and disorders (e.g., ischemia, cognitive decline, and anxiety), and other health problems (e.g., thrombosis, tumorigenesis, pancreatitis). The mechanisms behind these effects include antioxidation, anti-apoptosis, vasodilation, inflammation regulation, lipidemia control, etc., through the PI3K/Akt-ERK1/2/Nrf2/HO-1, Bcl-2/Bax, eNOS and other molecular signaling pathways. Both Danshen and Danshensu might be more effective than classical cardiovascular drugs, and their combination yields improved therapeutic efficiency. Here, we provide an overview of these drugs for a better understanding of Danshensu as a promising Chinese traditional medicine.
引用
收藏
页数:7
相关论文
共 95 条
[21]   Ischaemic conditioning and reperfusion injury [J].
Hausenloy, Derek J. ;
Yellon, Derek M. .
NATURE REVIEWS CARDIOLOGY, 2016, 13 (04) :193-209
[22]   Targeting Myocardial Reperfusion Injury - The Search Continues [J].
Hausenloy, Derek J. ;
Yellon, Derek M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11) :1073-1075
[23]   Regulation of cardiac hypertrophy by intracellular signalling pathways [J].
Heineke, Joerg ;
Molkentin, Jeffery D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (08) :589-600
[24]   Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease [J].
Herrington, William ;
Lacey, Ben ;
Sherliker, Paul ;
Armitage, Jane ;
Lewington, Sarah .
CIRCULATION RESEARCH, 2016, 118 (04) :535-546
[25]   The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge [J].
Heusch, Gerd ;
Gersh, Bernard J. .
EUROPEAN HEART JOURNAL, 2017, 38 (11) :774-+
[26]   Involvements of calcium channel and potassium channel in Danshen and Gegen decoction induced vasodilation in porcine coronary LAD artery [J].
Hu, Fan ;
Koon, Chi Man ;
Chan, Judy Yuet Wa ;
Lau, Kit Man ;
Kwan, Y. W. ;
Fung, Kwok Pui .
PHYTOMEDICINE, 2012, 19 (12) :1051-1058
[27]   Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway [J].
Hu, Tianxin ;
Wei, Guo ;
Xi, Miaomiao ;
Yan, Jiajia ;
Wu, Xiaoxiao ;
Wang, Yanhua ;
Zhu, Yanrong ;
Wang, Chao ;
Wen, Aidong .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (01) :83-94
[28]   Significance and Mechanisms of P-glycoprotein in Central Nervous System Diseases [J].
Huang, Liangliang ;
Li, Binbin ;
Li, Xiang ;
Liu, Ge ;
Liu, Rui ;
Guo, Jia ;
Xu, Baohui ;
Li, Yunman ;
Fang, Weirong .
CURRENT DRUG TARGETS, 2019, 20 (11) :1141-1155
[29]  
Huang S.Z, 2015, J N PHARM, V99, P87
[30]   The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents [J].
Jia, Yaoling ;
Dong, Xiaoyi ;
Zhou, Pengfei ;
Liu, Xinhua ;
Pan, Lilong ;
Xin, Hong ;
Zhu, Yi Zhun ;
Wang, Yang .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 :176-187